次世代の細胞株開発プラットフォームの構築

Speed to market is a critical factor in the industry. The development of a productive and stable cell line is the basis for of a high-performing bioprocess. 

Our 4Cell^® CHO platform saves time and costs while  maintaining exceptional quality DNA To RCB in 9 weeks with titers of up to 10g/L 

• Automated analysis with early selection of high-producer clones 
• 4Cell^® SmartCHO media maximises cell line productivity 
• Process intensification with high-inoculation fed-batch